What is it about?
As more and more people use direct-to-consumer genetic testing kits (like 23andme) to learn about their health and genetic health testing plays a bigger role in patient care, we examine how experts and patients differently navigate the uncertainty that comes with this new terrain.
Photo by julien Tromeur on Unsplash
Why is it important?
By showing how expert and patient perspectives on risk work together to make sense of genetic health, we argue that risk itself becomes a disease state.
Read the Original
This page is a summary of: Medicalizing risk: How experts and consumers manage uncertainty in genetic health testing, PLoS ONE, August 2022, PLOS,
You can read the full text:
The following have contributed to this page